DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 177 filers reported holding DIPLOMAT PHARMACY INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,696,000 | +497.2% | 424,121 | +631.0% | 0.00% | – |
| Q3 2019 | $284,000 | -30.0% | 58,018 | -13.0% | 0.00% | – |
| Q2 2019 | $406,000 | +83.7% | 66,700 | +75.0% | 0.00% | – |
| Q1 2019 | $221,000 | -23.3% | 38,110 | +78.3% | 0.00% | – |
| Q4 2018 | $288,000 | -74.9% | 21,379 | -63.8% | 0.00% | -100.0% |
| Q3 2018 | $1,148,000 | -44.0% | 59,133 | -26.3% | 0.00% | -50.0% |
| Q2 2018 | $2,050,000 | +32.2% | 80,223 | +4.2% | 0.00% | +100.0% |
| Q1 2018 | $1,551,000 | -2.8% | 76,980 | -3.1% | 0.00% | 0.0% |
| Q4 2017 | $1,596,000 | -36.4% | 79,460 | -34.4% | 0.00% | -66.7% |
| Q3 2017 | $2,510,000 | -33.2% | 121,188 | -52.2% | 0.00% | -25.0% |
| Q2 2017 | $3,756,000 | +356.4% | 253,781 | +391.3% | 0.00% | +300.0% |
| Q1 2017 | $823,000 | -53.7% | 51,656 | -63.4% | 0.00% | -50.0% |
| Q4 2016 | $1,778,000 | +34.8% | 141,173 | +199.9% | 0.00% | +100.0% |
| Q3 2016 | $1,319,000 | – | 47,069 | +470590.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 10 | -90.0% | 0.00% | – |
| Q1 2016 | $3,000 | -66.7% | 100 | -63.2% | 0.00% | – |
| Q4 2015 | $9,000 | -99.5% | 272 | -99.6% | 0.00% | -100.0% |
| Q3 2015 | $1,906,000 | +958.9% | 68,097 | +1560.5% | 0.00% | – |
| Q2 2015 | $180,000 | +500.0% | 4,101 | +382.5% | 0.00% | – |
| Q1 2015 | $30,000 | +15.4% | 850 | -9.6% | 0.00% | – |
| Q4 2014 | $26,000 | – | 940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|